{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:34:16Z","timestamp":1781224456319,"version":"3.54.1"},"reference-count":33,"publisher":"CMA Joule Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAJ Open"],"published-print":{"date-parts":[[2017,8,25]]},"DOI":"10.9778\/cmajo.20170048","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T20:10:39Z","timestamp":1504037439000},"page":"E662-E672","source":"Crossref","is-referenced-by-count":26,"title":["Model-based projection of health and economic effects of screening for hepatitis C in Canada"],"prefix":"10.9778","volume":"5","author":[{"given":"William W.L.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Erman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"382","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"2017082917103592000_5.3.E662.1","unstructured":"Kwong JC, Crowcroft NS, Campitelli MS, et al.; Ontario Burden of Infectious Disease Study Advisory Group. Ontario Burden of Infectious Disease Study (ONBOIDS): an OAHPP\/ICES report. Toronto: Ontario Agency for Health Protection and Promotion, Institute for Clinical Evaluative Sciences; 2010"},{"key":"2017082917103592000_5.3.E662.2","first-page":"3","article-title":"Seroprevalence of hepatitis B and C virus infections: results from the 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey.","volume":"24","author":"Rotermann","year":"2013","journal-title":"Health Rep"},{"key":"2017082917103592000_5.3.E662.3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.14745\/ccdr.v40i19a02","article-title":"Estimated prevalence of hepatitis C virus infection in Canada, 2011.","volume":"40","author":"Trubnikov","year":"2014","journal-title":"Can Commun Dis Rep"},{"key":"2017082917103592000_5.3.E662.4","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.121872"},{"key":"2017082917103592000_5.3.E662.5","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.140711"},{"key":"2017082917103592000_5.3.E662.6","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.9778\/cmajo.20160161","article-title":"Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysis.","volume":"5","author":"Wong","year":"2017","journal-title":"CMAJ Open"},{"key":"2017082917103592000_5.3.E662.7","doi-asserted-by":"crossref","first-page":"E605","DOI":"10.9778\/cmajo.20160008","article-title":"Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study.","volume":"4","author":"Marshall","year":"2016","journal-title":"CMAJ Open"},{"key":"2017082917103592000_5.3.E662.8","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.161521"},{"key":"2017082917103592000_5.3.E662.9","unstructured":"Wong WWL, Krahn M, Lee K, et al. CADTH Therapeutic Review. Drugs for chronic hepatitis C infection: cost-effectiveness analysis. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2016"},{"key":"2017082917103592000_5.3.E662.10","unstructured":"Census profile. 2011 census. Ottawa: Statistics Canada; 2012. Cat no 98-316-XWE"},{"key":"2017082917103592000_5.3.E662.11","unstructured":"CADTH Therapeutic Review. Drugs for chronic hepatitis C infection: clinical report. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2015"},{"key":"2017082917103592000_5.3.E662.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.40077.x"},{"key":"2017082917103592000_5.3.E662.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2004.0976.x"},{"key":"2017082917103592000_5.3.E662.14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.057182"},{"key":"2017082917103592000_5.3.E662.15","unstructured":"Ontario's use of funding provided by the federal hepatitis C undertaking agreement. Toronto: Government of Ontario; 2007"},{"key":"2017082917103592000_5.3.E662.16","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/692408"},{"key":"2017082917103592000_5.3.E662.17","unstructured":"TreeAge 2013 Professional. Williamstown (MA): TreeAge Software; 2013"},{"key":"2017082917103592000_5.3.E662.18","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X03261568"},{"key":"2017082917103592000_5.3.E662.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.2.228"},{"key":"2017082917103592000_5.3.E662.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.24.2088"},{"key":"2017082917103592000_5.3.E662.21","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.6011"},{"key":"2017082917103592000_5.3.E662.22","unstructured":"Guidelines for the economic evaluation of health technologies: Canada. 4th ed. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2017"},{"key":"2017082917103592000_5.3.E662.23","unstructured":"A statement from the pan-Canadian Pharmaceutical Alliance [press release]. Ottawa: Pan Canadian Pharmaceutical Alliance. 2017 Feb. 21"},{"key":"2017082917103592000_5.3.E662.24","first-page":"473","article-title":"How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.","volume":"146","author":"Laupacis","year":"1992","journal-title":"CMAJ"},{"key":"2017082917103592000_5.3.E662.25","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826090-00004"},{"key":"2017082917103592000_5.3.E662.26","unstructured":"Choosing interventions that are cost effective (WHO-CHOICE). Geneva: World Health Organization; 2005"},{"key":"2017082917103592000_5.3.E662.27","doi-asserted-by":"crossref","first-page":"e011821","DOI":"10.1136\/bmjopen-2016-011821","article-title":"Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluations.","volume":"6","author":"Coward","year":"2016","journal-title":"BMJ Open"},{"key":"2017082917103592000_5.3.E662.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008876"},{"key":"2017082917103592000_5.3.E662.29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-9"},{"key":"2017082917103592000_5.3.E662.30","unstructured":"Turnbull Government invests over $1 billion to cure HEP C [press release]. Australia: Minister of Health, Commonwealth of Australia; 2015"},{"key":"2017082917103592000_5.3.E662.31","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm Rep"},{"key":"2017082917103592000_5.3.E662.32","unstructured":"World Hepatitis Summit harnesses global momentum to eliminate viral hepatitis [press release]. Glasgow (UK): World Health Organization; 2015 Sept. 2"},{"key":"2017082917103592000_5.3.E662.33","unstructured":"Bolotin S, Garber G. Public Health Ontario grand rounds: population-based estimate of hepatitis C virus prevalence in Ontario presentation]. Toronto: Ontario Public Health Conference; 2016 Nov. 29."}],"container-title":["CMAJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9778\/cmajo.20170048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T18:39:04Z","timestamp":1570041544000},"score":1,"resource":{"primary":{"URL":"http:\/\/cmajopen.ca\/lookup\/doi\/10.9778\/cmajo.20170048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,25]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,8,29]]},"published-print":{"date-parts":[[2017,8,25]]}},"alternative-id":["10.9778\/cmajo.20170048"],"URL":"https:\/\/doi.org\/10.9778\/cmajo.20170048","relation":{},"ISSN":["2291-0026"],"issn-type":[{"value":"2291-0026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,25]]}}}